(Q2)Feb 28, 2024 | (Q1)Nov 30, 2023 | (Q2)Feb 28, 2023 | (Q1)Nov 30, 2022 | |
---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||
Cash flow from continuing operating activities | -177.87K | 65.18%-26.56K | 0 | -76.28K |
Net income from continuing operations | ---19.56K | 61.27%-17.34K | --0 | ---44.79K |
Unrealized gains and losses of investment securities | ---- | ---475 | ---- | --0 |
Other non cashItems | ---- | ---- | --0 | --88 |
Change In working capital | ---80.51K | 72.32%-8.74K | --0 | ---31.58K |
-Change in receivables | ---57.3K | 85.58%-7.21K | --0 | ---50K |
-Change in prepaid assets | ---8.77K | ---5.7K | --0 | --0 |
-Change in payables and accrued expense | ---14.44K | -77.36%4.17K | --0 | --18.42K |
Cash from discontinued investing activities | ||||
Operating cash flow | ---177.87K | 65.18%-26.56K | --0 | ---76.28K |
Investing cash flow | ||||
Cash flow from continuing investing activities | -317.5K | 747.50%50K | 0 | -7.72K |
Net PPE purchase and sale | ---317.5K | --0 | --0 | ---7.72K |
Net other investing changes | --0 | --50K | ---- | ---- |
Cash from discontinued investing activities | ||||
Investing cash flow | ---317.5K | 747.50%50K | --0 | ---7.72K |
Financing cash flow | ||||
Cash flow from continuing financing activities | 0 | 0 | 0 | 0 |
Net common stock issuance | --0 | --0 | --0 | --0 |
Cash from discontinued financing activities | ||||
Financing cash flow | --0 | --0 | --0 | --0 |
Net cash flow | ||||
Beginning cash position | -2.15%1.02M | -11.50%1M | --1.05M | --1.13M |
Current changes in cash | ---495.37K | 127.91%23.44K | --0 | ---84K |
End cash Position | -49.50%528.29K | -2.15%1.02M | --1.05M | --1.05M |
Free cash from | ---495.37K | 68.38%-26.56K | --0 | ---84K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.